Sareum cancer link with Roche
Cambridge drug discovery business Sareum Holdings has entered into a cancer collaboration with world-leading healthcare group, Roche.Sareum will provide protein structure determination capabilities to accelerate Roche's cancer drug discovery research.
The Cambridge company has highly-rated skills in protein engineering and high throughput protein structure determination.
This expertise wlll illustrate the precise nature of how Roche's potential drug candidates interact with target receptor proteins and support Roche's scientists in their search for new and imp-roved cancer therapeutics.
Financial terms of the agreement were not disclosed.